SIMULATIONS PLUS INC (SLP) Stock Price, Forecast & Analysis
NASDAQ:SLP • US8292141053
SLP Key Statistics, Chart & Performance
The current stock price of SLP is 12.09 USD. In the past month the price decreased by -35.1%. In the past year, price decreased by -58.28%.
SLP Technical Analysis
SLP Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to SLP. SLP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
SLP Financial Highlights
Over the last trailing twelve months SLP reported a non-GAAP Earnings per Share(EPS) of 0.6. The EPS increased by 50% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -46.61% | ||
| ROE | -50.54% | ||
| Debt/Equity | 0 |
SLP Forecast & Estimates
11 analysts have analysed SLP and the average price target is 25.25 USD. This implies a price increase of 108.81% is expected in the next year compared to the current price of 12.09.
For the next year, analysts expect an EPS growth of -5.97% and a revenue growth 2.12% for SLP
SLP Ownership
SLP Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 20.88 | 29.006B | ||
| WAY | WAYSTAR HOLDING CORP | 15.76 | 4.668B | ||
| DOCS | DOXIMITY INC-CLASS A | 14.34 | 4.507B | ||
| HTFL | HEARTFLOW INC | N/A | 1.959B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 231.19 | 1.099B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.092B | ||
| CERT | CERTARA INC | 12.25 | 1.05B | ||
| SDGR | SCHRODINGER INC | N/A | 869.188M | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 4.51 | 831.604M | ||
| TDOC | TELADOC HEALTH INC | N/A | 824.678M |
Related stock screener links
View all stocks in the Health Care Technology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SLP
Company Profile
Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The company is headquartered in Research Triangle Park, North Carolina and currently employs 212 full-time employees. The company operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The firm operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. The company delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
Company Info
SIMULATIONS PLUS INC
800 Park Offices Drive, Suite 401
RESEARCH TRIANGLE PARK NORTH CAROLINA 93534 US
CEO: Shawn O'Connor
Employees: 212
Phone: 16617237723
SIMULATIONS PLUS INC / SLP FAQ
What does SIMULATIONS PLUS INC do?
Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The company is headquartered in Research Triangle Park, North Carolina and currently employs 212 full-time employees. The company operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The firm operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. The company delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
Can you provide the latest stock price for SIMULATIONS PLUS INC?
The current stock price of SLP is 12.09 USD. The price increased by 2.37% in the last trading session.
Does SIMULATIONS PLUS INC pay dividends?
SIMULATIONS PLUS INC (SLP) has a dividend yield of 0.61%. The yearly dividend amount is currently 0.
What is the ChartMill technical and fundamental rating of SLP stock?
SLP has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Where is SIMULATIONS PLUS INC (SLP) stock traded?
SLP stock is listed on the Nasdaq exchange.
What sector and industry does SIMULATIONS PLUS INC belong to?
SIMULATIONS PLUS INC (SLP) operates in the Health Care sector and the Health Care Technology industry.
Can you provide the number of employees for SIMULATIONS PLUS INC?
SIMULATIONS PLUS INC (SLP) currently has 212 employees.